BCR and diffuse large B-cell lymphoma: The proliferation of both OxPhos- and BCR-DLBCL cells was unaffected by UK5099 at all glutamine concentrations (Fig. 2A), suggesting that MPC inhibition does not induce increased glutamine consumption or dependence in DLBCLs.